European Commission Initiative on Breast Cancer (ECIBC) recognizes the Anticancer Fund as a stakeholder
The Anticancer Fund is recognized as a stakeholder of the European Commission Initiative on Breast Cancer (ECIBC). ECIBC involves 35 countries collaborating together around two working groups, composed out of medical doctors, researches and patients. The first group ‘The Guidelines Development Group’ develops evidence-based European guidelines for breast cancer screening and diagnosis (European Breast Guidelines). The second group ‘The Quality Assurance Scheme Development Group’ creates the European Quality Assurance Scheme for Breast Cancer Services (European QA scheme) to establish common quality and safety requirements, developed from the patient’s point of view. ECIBC works in a transparent way, meaning that all information is available and shared with the public.